OasisLMS

This webinar explores an innovative combined approach to glioblastoma treatment that integrates intraoperative fluorescence-guided surgery (FGS) with photodynamic therapy (PDT). The session will discuss how 5-aminolevulinic acid (5-ALA), and other fluorophores help neurosurgeons better visualize tumor boundaries during resection. In addition, intraoperative photodynamic therapy (PDT) will be explored as a complementary approach to target residual cancer cells. Our presenter and Chair of the AANS/CNS Tumor Section, Dr. Costas Hadjipanayis, will discuss clinical applications, research outcomes, and ongoing trials of this combined approach, highlighting its potential to improve extent of resection and local tumor control in glioblastoma patients.

Speaker	,Randy D'Amico, MD Raj Mukherjee, MD, MPH Ashish Shah, MD
Moderator	Costas Hadjipanayis, MD Yoshua Esquenazi, MD Ankush Chandra, MD, MS
Planner	Ankush Chandra, MD, MS Yoshua Esquenazi, MD

Upon completion of this activity, participants should be able to:
1. Discuss the unmet need of intraoperative visualization of GBM and the difficulty with local recurrence of GBM tumors after surgical resection. 
2. Discuss the principles and clinical applications of fluorescence-guided surgery (FGS) in glioblastoma diagnosis and management, including the mechanisms of 5-ALA and near-infrared fluorophores in enhancing tumor visualization and improving extent of resection. 
3. Describe the implementation of photodynamic therapy as a complementary treatment for residual glioblastoma cells, light delivery techniques, and evidence for improved local tumor control. 

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AANS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity was published in June 2025. Credit may be obtained until 06/04/2026.

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Education, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.

Those who have disclosed a relationship with ineligible companies are listed below.

All disclosed financial relationships have been mitigated in accordance with ACCME standards.

Name	Relationship/Company
Costas Hadjipanayis, MD	Consultant - Fuoguide, Hemerion, Integra Lifesciences, Synaptive Medical, True Digital Surgery

Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships or conflict of interest to disclose for this activity.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration for incorporation into practice. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.